Lexicon Pharmaceuticals Price Chart
Lexicon Pharmaceuticals Volume Chart
Lexicon Pharmaceuticals Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
-0.02(-1.23%)
| Open | $1.63 |
|---|---|
| Close | $1.61 |
| Low | $1.61 |
| Low Change | -0.02 (-1.23%) |
| High | $1.64 |
| High Change | +0.01 (+0.61%) |
| Range | $0.03 |
| Volume | 1.588K |
| Dollar Volume | $2.56K |
Regular Trading Hours Yesterday
+0.04(+2.53%)
| Open | $1.58 |
|---|---|
| Close | $1.62 |
| Low | $1.57 |
| Low Change | -0.02 (-0.95%) |
| High | $1.63 |
| High Change | +0.05 (+3.16%) |
| Range | $0.07 |
| Volume | 1.052M |
| Dollar Volume | $1.70M |
Premarket Yesterday
+0.01(+0.63%)
| Open | $1.58 |
|---|---|
| Close | $1.59 |
| Low | $1.58 |
| Low Change | 0.00 (0.00%) |
| High | $1.62 |
| High Change | +0.04 (+2.53%) |
| Range | $0.04 |
| Volume | 10.6K |
| Dollar Volume | $16.85K |
Lexicon Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $1.64 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.73 |
| 20 Day Moving Average (SMA20) | $1.72 |
| 50 Day Moving Average (SMA50) | $1.65 |
| 100 Day Moving Average (SMA100) | $1.47 |
| 200 Day Moving Average (SMA200) | $1.37 |
Lexicon Pharmaceuticals Statistics
| Average Volume (30 Days) | 2.19M |
|---|---|
| P/E Ratio (Current) | -13.83 |
| EPS (Current) | -$0.12 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 1.64 |
| Current Ratio | 4.88 |
| Quick Ratio | 4.87 |
| Debt to Equity | 0.50 |
| Enterprise Value | $722.99M |
| EV to EBITDA | -14.92 |
| EV to Sales | 14.56 |
| Price to Book | 6.54 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 14.17 |
| Return on Assets | -0.27% |
| Return on Equity | -0.47% |
Lexicon Pharmaceuticals Stock Splits
There has been 1 stock split for Lexicon Pharmaceuticals (LXRX). The reverse stock split occured on May 21, 2015 and reduced the outstanding shares at a ratio of 7:1.
| Date | Type | Ratio |
|---|---|---|
| May 21, 2015 | Reverse | 7:1 |
Lexicon Pharmaceuticals Dividends
There have been no dividends for Lexicon Pharmaceuticals (LXRX).